320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM
Komrokii R, Zeidan A, Al Ali N, Padron E, Lancet J, Steensma D, Dezern A, Roboz G, Jabbour E, Sekeres M, Garcia-Manero G, List A. 320 RISK STRATIFICATION OF THERAPY-RELATED MYELODYSPLASTIC SYNDROMES (T-MDS): A REPORT ON BEHALF OF THE MDS CLINICAL RESEARCH CONSORTIUM. Leukemia Research 2015, 39: s158-s159. DOI: 10.1016/s0145-2126(15)30321-0.Peer-Reviewed Original Research